Skip to main content
. Author manuscript; available in PMC: 2012 Aug 26.
Published in final edited form as: Vaccine. 2011 Jun 23;29(37):6292–6300. doi: 10.1016/j.vaccine.2011.06.027

Figure 1.

Figure 1

Schematic representation of the primary structure of S.mutans Antigen I/II. The truncated NR21 and A3VP1 polypeptides used as antigens in the immunoassays described in this report are indicated.